Arenobufagin can inhibit AKT with involvement of Phosphatase and tensin homolog (PTEN) activation as well as PDK1 and PI3K inhibition, and induces apoptosis in HCC cells. This evidence concerns the gene PTEN and hepatocellular carcinoma.